2023³â °í·Á´ëÇб³ ¾È¾Ïº´¿ø CAR-TÇ×¾ÏÄ¡·á ½ÉÆ÷Áö¾ö : 2023-11-11
±³À°ÀÏÀÚ : 2023-11-11
±³À°Àå¼Ò : ¼ººÏ±¸ °í·Á´ë·Î 73 °í·Á´ëÇб³ ¾È¾Ïº´¿ø ½Å°ü 5Ãþ ¸ÞµðÈú Ȧ
±³À°ÁÖÁ¦ : 2023³â °í·Á´ëÇб³ ¾È¾Ïº´¿ø CAR-TÇ×¾ÏÄ¡·á ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : °í·Á´ëÇб³¾È¾Ïº´¿ø
´ã´çÀÚ : ±èÁöÀº
¿¬¶ôó : 02-920-5690
À̸ÞÀÏ : hoekumc@gmail.com
±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀÎ : 30¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11¿ù 11ÀÏ ¸ÞµðÈúȦ (½Å°ü 5Ãþ) 09:30~10:00 Currnet challeges of CAR T-cell therapy in adult B-cell lymphoma ±è¼®Áø(¼¿ï»ï¼ºº´¿ø)
±³À°½Ã°£ 11¿ù 11ÀÏ ¸ÞµðÈúȦ (½Å°ü 5Ãþ) 10:00~10:30 CAR-T cell therapy and multiple myeloma º¯ÀÚ¹Î(¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 11¿ù 11ÀÏ ¸ÞµðÈúȦ (½Å°ü 5Ãþ) 10:30~11:00 Status and Challenges of CAR T-cell therapy in childhood cancer ±èÇý¸®(¼¿ï¾Æ»êº´¿ø)
ÈÞ½Ä 11¿ù 11ÀÏ 11:00~11:20 ÈÞ½Ä ( )
±³À°½Ã°£ 11¿ù 11ÀÏ ¸ÞµðÈúȦ (½Å°ü 5Ãþ) 11:20~11:50 CAR-T ¼¼Æ÷󸮸¦ À§ÇÑ ÀÎü¼¼Æ÷°ü¸®¾÷ Çã°¡ ¹× ³ë¹ÙƼ½º ÀÎÁõ ÀýÂ÷ Á¤ÇöÈ£(³ë¹ÙƼ½ºÄÚ¸®¾Æ)
±³À°½Ã°£ 11¿ù 11ÀÏ ¸ÞµðÈúȦ (½Å°ü 5Ãþ) 11:50~12:20 CAR-T Ä¡·á¸¦ À§ÇÑ ÀÓ»ó ¿µ¿ªÀÇ Áغñ ¹× ÁÖÀÇ »çÇ× °°¡¿ø(°í·Á´ëÇб³¾È¾Ïº´¿ø)
½Ä»ç 11¿ù 11ÀÏ 12:20~13:00 ½Ä»ç ( )
±³À°½Ã°£ 11¿ù 11ÀÏ ¸ÞµðÈúȦ (½Å°ü 5Ãþ) 13:00~13:30 Â÷¼¼´ë CAR-T °³¹ß Àü·« ÃÖ°æÈ£(¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ »ýÈÇб³½Ç)
±³À°½Ã°£ 11¿ù 11ÀÏ ¸ÞµðÈúȦ (½Å°ü 5Ãþ) 13:30~14:00 ±Þ¼º °ñ¼ö¼º¹éÇ÷º´¿¡¼ CAR-T Àû¿ë Á¶º´½Ä(¼¿ï¼º¸ðº´¿ø)